The fact
Pharmaceutical companies like Boehringer Ingelheim criticize a lack of transparency.
Drug price regulation could impact pharmaceutical innovation.
Click the link to read an article on the topic:
Pharmaceutical companies like Boehringer Ingelheim criticize a lack of transparency.
Drug price regulation could impact pharmaceutical innovation.